Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total No. of companies carrying out R&D in Biotechnology 1.010 69 1.078 %Companies according to biotechnology used: Genetic code 34 49 35 %Companies according to biotechnology used: Functional units 41 54 42 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 25 48 27 %Companies according to biotechnology used: Bioprocesses 48 59 49 %Companies according to biotechnology used: Sub-cellular organisms 7 12 8 %Companies according to biotechnology used: Bio-computing 22 22 22 %Companies according to biotechnology used: Nanobiotechnology 14 18 14 %Companies according to biotechnology used: Other 12 8 12 Companies in which biotechnology activities are: Main and/or exclusive 511 15 526 Companies in which biotechnology activities are: A secondary line of business 155 18 173 Companies in which biotechnology activities are: A tool necessary for production 344 35 379 %Company by field(s) of ultimate application of biotechnology use: Human Health 48 50 48 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 21 5 20 %Company by field(s) of ultimate application of biotechnology use: Food products 32 36 33 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24 21 24 %Company by field(s) of ultimate application of biotechnology use: Environment 15 15 15 %Company by field(s) of ultimate application of biotechnology use: Industry 14 6 14 Personnel in R&D in biotechnology (no. of persons) 7.849 2.342 10.191 Personnel in R&D in biotechnology (no. of persons): Researchers 4.469 1.305 5.774 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 3.380 1.037 4.417 Personnel in R&D in biotechnology (no. of persons): women 4.199 1.326 5.525 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.320 695 3.015 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 1.879 631 2.511 Personnel in R&D in biotechnology (FTE) 5.530,1 1.661,2 7.191,4 Personnel in R&D in biotechnology (FTE): Researchers 3.333 943,6 4.276,6 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.197,1 717,6 2.914,7 Personnel in R&D in biotechnology (FTE): women 3.061 924,4 3.985,4 Personnel in R&D in biotechnology (FTE): (women) Researchers 1.742,1 491,9 2.234 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.318,9 432,5 1.751,4 Internal expenditure on R&D (thousands of euros) 441.736 136.435 578.171 1) By nature of the expense: Current expenses 387.035 130.565 517.601 1.1) Remuneration to researchers 158.420 55.335 213.755 1.2) Remuneration to technicians and assistants 74.027 24.413 98.440 1.3) Other current expenses 154.588 50.818 205.406 2) By nature of the expense: Capital expenses 54.701 5.870 60.570 2.1) Land and buildings 22.554 54 22.609 2.2) Equipment and instruments 30.685 5.483 36.169 2.3) Acquisition of specific R&D software 1.461 332 1.793 1) By origin of the funds: National funds 379.550 108.064 487.615 1.1) Own funds 249.390 81.068 330.459 1.2) From companies 32.831 12.630 45.462 1.3) Public Administration funds 53.162 13.028 66.189 1.4) From Universities 25.148 . 25.148 1.5) From non profit private institutions 19.019 1.338 20.357 1) By origin of the funds: Foreign funds 62.186 28.371 90.556 2.1) From EU programmes 18.782 2.150 20.932 2.2) Other foreign funds 43.403 26.221 69.624 Purchase of R&D services in biotechnology (thousands of euros) 111.514 54.508 166.022 Purchase of R&D services in biotechnology (thousands of euros): In Spain 67.448 30.007 97.455 Purchase of R&D services in biotechnology (thousands of euros): Abroad 44.065 24.501 68.567 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 47 30 46 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 12 13 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 14 16 14 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 13 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 18 14 17 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17 12 17 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 18 17 18 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 35 36 35 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 50 34 49 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 22 9 21 % Companies that have requested biotechnology patents in Biotechnology 15 21 15 Number of patents requested 451 75 526 % Companies with income of an international origin related to biotechnological activities 26,4 19,1 26 % Turnover representing income of an international origin related to biotechnological activities 6,5 0,8 1,4 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 51,6 76,3 63,8 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 48,4 23,7 36,2 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 85,6 97,7 91,6 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 1,4 0,5 0,9 % Income of an international origin related with activities according to the classification: Operating source abroad 3 0,7 1,9 % Income of an international origin related with activities according to the classification: Other 10,1 1,1 5,6 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute